Scarica l'app Stockscreener
249.20
0.13%
-0.4176
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LH Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Labcorp Holdings Inc Borsa (LH) Ultime notizie
Employees seek leadership development—but access gaps may hold them back, new report finds - GlobeNewswire Inc.
Labcorp Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72 - simplywall.st
HSBC Downgrades Labcorp to Hold From Buy, $260 Price Target - MarketScreener
Labcorp Declares Quarterly Dividend, Enhancing Shareholder Value - TipRanks
Labcorp Declares Quarterly Dividend - PR Newswire
Privia Health appoints former Labcorp CTO to board of directors - Investing.com
Healthcare Tech Expert Joins Privia Health Board: Former Labcorp CTO to Drive Digital Innovation - Stock Titan
What Makes Labcorp (LH) a New Buy Stock - Nasdaq
Labcorp Holdings stock hits 52-week high at $264.04 By Investing.com - Investing.com Australia
Labcorp Holdings stock hits 52-week high at $264.04 - Investing.com
Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low (NYSE:LH) - Seeking Alpha
LabCorp's Credit Facility Overhaul: A Playbook for Sustained Growth in Diagnostics - AInvest
Labcorp Holdings Secures $1 Billion Credit Facility - TipRanks
Labcorp to Announce Second Quarter Financial Results on July 24, 2025 - GuruFocus
Labcorp Holdings to Announce Q2 2025 Financial Results - TipRanks
Labcorp Holdings (LH) Receives Price Target Increase from Barcla - GuruFocus
Barclays Adjusts Labcorp (LH) Price Target to $275 Amid Q2 Outlook | LH Stock News - GuruFocus
Fortrea Holdings Inc. Stockholders Should Contact Robbins - GlobeNewswire
Is Labcorp Holdings Stock Outperforming the Dow? - MSN
Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge? - Nasdaq
Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care - marketscreener.com
Labcorp Revolutionizes Healthcare Testing with New 1000+ Biomarker Platform for Holistic Medicine - Stock Titan
Baird Adjusts Price Target on Labcorp Holdings to $290 From $268, Maintains Outperform Rating - MarketScreener
Morgan Stanley Hikes Labcorp (LH) Holdings Price Target to $283 Affirms ‘Overweight’ Rating - Yahoo Finance
Labcorp Shares Soar 1.11% on Strong Q1 Earnings - AInvest
FTRE INVESTOR DEADLINE: Robbins Geller Rudman & Dowd Announces that Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE - FinancialContent
Kaplan Fox Reminds Fortrea Holdings Inc. (FTRE) Investors of a Securities Class Action Deadline on August 1, 2025 - FinancialContent
Class Standing Issues Still Murky After Justices Punt LabCorp - Law360
Labcorp (LH) Gains Exclusive 3D Liver Models from Predictive Onc - GuruFocus
Labcorp director Kerrii Anderson sells shares worth $130,000 By Investing.com - Investing.com Canada
Labcorp director Kerrii Anderson sells shares worth $130,000 - Investing.com Australia
Predictive Oncology Develops 3D Liver Toxicity Models for Labcorp - marketscreener.com
Predictive Oncology Inc. Develops Functional 3D Organoid Models Exclusively for Labcorp - MarketScreener
Kaplan Fox Encourages Investors of Fortrea Holdings Inc. (FTRE) to Contact the Firm Before Lead Plaintiff Deadline on August 1, 2025 - The Globe and Mail
Investing in Labcorp Holdings (NYSE:LH) five years ago would have delivered you a 85% gain - simplywall.st
Predictive Oncology Inc. Develops Exclusive 3D Organoid Models for Labcorp to Enhance Drug Discovery and Safety Evaluation - Nasdaq
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp - Yahoo Finance
Labcorp Hldgs (LH) Price Target Raised by Morgan Stanley | LH St - GuruFocus
Kirby McInerney LLP Reminds Fortrea Holdings Inc. (FTRE) Investors of Class Action Filing and Encourages Investors to Contact the Firm - FinancialContent
Kaplan Fox Alerts Investors to a Securities Class Action Against Fortrea Holdings Inc. (FTRE)Deadline is August 1, 2025 - The Globe and Mail
Labcorp v. Davis Challenge Regarding Uninjured Class Members Dismissed as Improvidently Granted - Wilson Sonsini
What 8 Analyst Ratings Have To Say About Labcorp Hldgs - Benzinga
Just One Day Away – Register Now for HMG Strategy’s 9th Annual New York CISO & Technology Leadership Summit on June 12 - GlobeNewswire Inc.
Labcorp Hldgs (LH) Price Target Raised by Morgan Stanley | LH Stock News - GuruFocus
Analyst Boosts Price Target for Labcorp (LH) Amid Positive Growt - GuruFocus
Morgan Stanley Raises Price Target on Labcorp Holdings to $283 From $270 - marketscreener.com
LabCorp stock hits 52-week high at $258.7 amid robust growth By Investing.com - Investing.com South Africa
Justice Kavanaugh Signals One Conservative Vote in Labcorp Toward Imposing a Pre-Certification Standing Requirement Under FRCP 23 - The National Law Review
LabCorp stock hits 52-week high at $258.7 amid robust growth - Investing.com India
Labcorp Holdings Inc. Shares Soar 1.46% to 52-Week High on Strong Q1 Earnings - AInvest
FTRE INVESTOR ALERT: Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
The Supreme Court's dismissal of Labcorp v. Davis - Daily Journal
SCOTUS Declines to Decide Fate of Classes with Uninjured Members: 8-1 Decision in LabCorp Leaves Unresolved Whether Rule 23 Allows Certification for a Class Containing Members Who Lack Standing - The National Law Review
SCOTUS DECLINES TO DECIDE FATE OF CLASSES WITH UNINJURED MEMBERS: 8-1 Decision In LabCorp Leaves Unresolved Whether Rule 23 Allows Certification For A Class Containing Members Who Lack Standing - TCPAWorld
0.57%
0.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):